KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Total Current Liabilities (2019 - 2025)

Clover Health Investments' Total Current Liabilities history spans 7 years, with the latest figure at $208.8 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 2.2% year-over-year to $208.8 million; the TTM value through Dec 2025 reached $208.8 million, down 2.2%, while the annual FY2025 figure was $208.8 million, 2.2% down from the prior year.
  • Total Current Liabilities reached $208.8 million in Q4 2025 per CLOV's latest filing, up from $193.4 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $2.2 billion in Q1 2022 to a low of $173.0 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $563.7 million, with a median of $302.1 million recorded in 2024.
  • Peak YoY movement for Total Current Liabilities: surged 276633.67% in 2021, then crashed 67.9% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $371.9 million in 2021, then grew by 16.03% to $431.5 million in 2022, then plummeted by 39.49% to $261.1 million in 2023, then dropped by 18.23% to $213.5 million in 2024, then fell by 2.2% to $208.8 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Total Current Liabilities are $208.8 million (Q4 2025), $193.4 million (Q3 2025), and $201.9 million (Q2 2025).